Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myeloproliferative Disorders | 4 | 2023 | 606 | 1.330 |
Why?
|
| Photoreceptor Cells, Vertebrate | 3 | 2014 | 204 | 0.920 |
Why?
|
| Thymoma | 1 | 2023 | 186 | 0.790 |
Why?
|
| Lymphopenia | 1 | 2023 | 285 | 0.750 |
Why?
|
| Thymus Neoplasms | 1 | 2023 | 268 | 0.740 |
Why?
|
| Blood Cells | 1 | 2020 | 309 | 0.640 |
Why?
|
| Parvoviridae Infections | 1 | 2017 | 35 | 0.610 |
Why?
|
| Bone Marrow | 5 | 2023 | 2948 | 0.610 |
Why?
|
| Retinal Drusen | 2 | 2014 | 66 | 0.590 |
Why?
|
| Hematologic Neoplasms | 3 | 2023 | 1832 | 0.570 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2023 | 3523 | 0.530 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 689 | 0.500 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2020 | 501 | 0.490 |
Why?
|
| Geographic Atrophy | 1 | 2014 | 66 | 0.460 |
Why?
|
| Vision Disorders | 1 | 2021 | 1058 | 0.460 |
Why?
|
| Testicular Neoplasms | 1 | 2020 | 804 | 0.460 |
Why?
|
| Dendritic Cell Sarcoma, Follicular | 2 | 2021 | 30 | 0.380 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2703 | 0.340 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3586 | 0.300 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 5686 | 0.290 |
Why?
|
| Mutation | 8 | 2023 | 29786 | 0.270 |
Why?
|
| Macular Degeneration | 1 | 2013 | 980 | 0.260 |
Why?
|
| Macrophages | 1 | 2020 | 5655 | 0.260 |
Why?
|
| Liver | 1 | 2021 | 7474 | 0.260 |
Why?
|
| Heart Transplantation | 1 | 2017 | 3110 | 0.240 |
Why?
|
| Leber Congenital Amaurosis | 2 | 2014 | 33 | 0.230 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
| Hematopoiesis | 2 | 2021 | 2072 | 0.200 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2019 | 1581 | 0.190 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2022 | 169 | 0.190 |
Why?
|
| Tonsillar Neoplasms | 1 | 2020 | 51 | 0.180 |
Why?
|
| Blood Cell Count | 1 | 2020 | 403 | 0.170 |
Why?
|
| Liver Function Tests | 1 | 2021 | 528 | 0.170 |
Why?
|
| Histiocytosis, Sinus | 1 | 2019 | 47 | 0.170 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 294 | 0.160 |
Why?
|
| Cell Size | 1 | 2020 | 643 | 0.160 |
Why?
|
| Pathology, Molecular | 1 | 2021 | 326 | 0.160 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2017 | 37 | 0.150 |
Why?
|
| Red-Cell Aplasia, Pure | 1 | 2017 | 30 | 0.150 |
Why?
|
| Dendritic Cells | 3 | 2023 | 2725 | 0.150 |
Why?
|
| Parvovirus B19, Human | 1 | 2017 | 38 | 0.150 |
Why?
|
| Orchiectomy | 1 | 2020 | 474 | 0.150 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2019 | 236 | 0.150 |
Why?
|
| Bone Marrow Examination | 1 | 2017 | 157 | 0.150 |
Why?
|
| Cyclin D1 | 1 | 2019 | 463 | 0.150 |
Why?
|
| Receptors, Cell Surface | 2 | 2020 | 2866 | 0.150 |
Why?
|
| Erythroblasts | 1 | 2017 | 150 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 17446 | 0.150 |
Why?
|
| Plasma Cells | 1 | 2020 | 591 | 0.140 |
Why?
|
| Vacuoles | 1 | 2017 | 230 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 705 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2018 | 535 | 0.140 |
Why?
|
| DNA Mismatch Repair | 1 | 2020 | 426 | 0.140 |
Why?
|
| Nuclear Proteins | 2 | 2023 | 5853 | 0.140 |
Why?
|
| Cell Transformation, Viral | 1 | 2017 | 565 | 0.140 |
Why?
|
| Virus Activation | 1 | 2017 | 319 | 0.130 |
Why?
|
| Lens, Crystalline | 1 | 2017 | 388 | 0.130 |
Why?
|
| Janus Kinase 2 | 1 | 2018 | 528 | 0.130 |
Why?
|
| cis-trans-Isomerases | 1 | 2014 | 44 | 0.130 |
Why?
|
| Humans | 26 | 2024 | 744343 | 0.130 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2019 | 604 | 0.130 |
Why?
|
| Lymph Nodes | 2 | 2024 | 3474 | 0.120 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 57776 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2019 | 541 | 0.120 |
Why?
|
| Retinal Cone Photoreceptor Cells | 2 | 2012 | 177 | 0.120 |
Why?
|
| Fovea Centralis | 1 | 2014 | 119 | 0.120 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1880 | 0.120 |
Why?
|
| Ophthalmoscopy | 1 | 2014 | 176 | 0.120 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2013 | 13 | 0.110 |
Why?
|
| Translocation, Genetic | 1 | 2019 | 1420 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1613 | 0.110 |
Why?
|
| Neoplasms | 1 | 2021 | 21683 | 0.110 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 847 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1526 | 0.100 |
Why?
|
| Macula Lutea | 1 | 2013 | 151 | 0.100 |
Why?
|
| Guanylate Cyclase | 1 | 2012 | 201 | 0.100 |
Why?
|
| Cell Lineage | 1 | 2020 | 2504 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 2 | 2014 | 2657 | 0.100 |
Why?
|
| Middle Aged | 11 | 2021 | 213383 | 0.090 |
Why?
|
| Aged | 9 | 2020 | 163280 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 2019 | 2969 | 0.090 |
Why?
|
| Sarcoma | 1 | 2021 | 1897 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 1354 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2020 | 4026 | 0.080 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2019 | 1352 | 0.080 |
Why?
|
| Male | 14 | 2022 | 350118 | 0.080 |
Why?
|
| Retinitis Pigmentosa | 1 | 2012 | 386 | 0.080 |
Why?
|
| Biopsy | 1 | 2021 | 6756 | 0.080 |
Why?
|
| Eye Proteins | 1 | 2012 | 646 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 12959 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2012 | 372 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 1970 | 0.080 |
Why?
|
| Retinal Degeneration | 1 | 2012 | 415 | 0.080 |
Why?
|
| Neutrophils | 1 | 2020 | 3719 | 0.080 |
Why?
|
| Alleles | 1 | 2019 | 6933 | 0.080 |
Why?
|
| Adult | 10 | 2020 | 214055 | 0.070 |
Why?
|
| Retina | 1 | 2017 | 2616 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 11366 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 14722 | 0.060 |
Why?
|
| Genotype | 1 | 2019 | 12951 | 0.060 |
Why?
|
| Female | 13 | 2024 | 380194 | 0.060 |
Why?
|
| SOXC Transcription Factors | 1 | 2023 | 40 | 0.060 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2023 | 39 | 0.060 |
Why?
|
| Gene Rearrangement | 2 | 2019 | 1179 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2012 | 2564 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5442 | 0.060 |
Why?
|
| Interferon Regulatory Factors | 1 | 2023 | 270 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 12072 | 0.050 |
Why?
|
| Graft Rejection | 2 | 2024 | 4397 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2017 | 21746 | 0.040 |
Why?
|
| Aging | 1 | 2017 | 8664 | 0.040 |
Why?
|
| Adolescent | 4 | 2022 | 85781 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 234 | 0.040 |
Why?
|
| Cytogenetic Analysis | 1 | 2019 | 295 | 0.040 |
Why?
|
| Lipofuscin | 1 | 2017 | 44 | 0.040 |
Why?
|
| Young Adult | 3 | 2020 | 56430 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2022 | 2649 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 35421 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1357 | 0.030 |
Why?
|
| Visual Acuity | 2 | 2014 | 2530 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2023 | 4776 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1660 | 0.030 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2020 | 477 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2023 | 2258 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1850 | 0.030 |
Why?
|
| Graft Survival | 1 | 2024 | 3737 | 0.030 |
Why?
|
| Eye Movements | 1 | 2014 | 507 | 0.020 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2012 | 195 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2012 | 698 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 2948 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4186 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5720 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12788 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 12354 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2024 | 77449 | 0.020 |
Why?
|
| Child | 3 | 2021 | 77709 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9239 | 0.010 |
Why?
|
| DNA | 1 | 2014 | 7301 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2012 | 41006 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29063 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14557 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 18029 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39050 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 35136 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 40561 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 63114 | 0.000 |
Why?
|
| Mice | 1 | 2012 | 81183 | 0.000 |
Why?
|
| Animals | 1 | 2012 | 168757 | 0.000 |
Why?
|
Concepts
(150)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_